Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Cardano Is at the Forefront of the Decentralized Finance Movement

By Chris Lau, InvestorPlace Contributor

Cardano is volatile, like any other cryptocurrency or altcoin, giving speculators plenty of trading opportunities ahead

Coupang Stock Will Increase in Price From Here

By Chris Lau, InvestorPlace Contributor

CPNG stock trades at extremely high valuations as markets bet on the SoftBank-backed prospects exceeding expectations

7 Stocks to Buy Until the Semiconductor Shortage Ceases

By Chris Lau, InvestorPlace Contributor

Investors have more upside in companies that make semiconductors and are unaffected from the shortage disrupting other markets.

QuantumScape Is Under Fire From Short-Sellers, but Should Pull Through Nicely

By Chris Lau, InvestorPlace Contributor

QS stock needs to survive a short-selling attack now as bears bet against its advanced battery technology and innovation claims

Why Zomedica Stock is a Pure Gamble Right Now

By Chris Lau, InvestorPlace Contributor

ZOM stock double peaked last month before falling sharply, as investors await for Truforma's launch to pay off handsomely.

Load More